Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Genmab Enters Commercial License Agreement with Novo Nordisk for DuoBody Technology

By: via Benzinga
Genmab A/S (OTC: GNMSF) announced today it has entered an agreement to grant Novo Nordisk (NYSE: NVO) commercial licenses to use the ...
Related Stocks:
Genmab A/S Novo Nordisk A/S ADR
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.